Leading pharmaceutical firms’ sales up 11.5% in second quarter

The combined sales of the 10 major domestic pharmaceutical manufacturers in the second quarter of this year marked a growth rate of 11.5 percent, while their combined operating income plunged by 1.2 percent, according to Good Morning Shinhan Securities Co..

The favorable business performance in the second quarter resulted from robust sales of flagship products, including Stilen, Amodipin and...